CONRIG PHARMA ApS: Financial statements 2025
CVR: 33373236
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.
- Gross Profit
- DKK -98,936
- Profit/Loss
- DKK -95,786
- Equity
- DKK 0
- Total Assets
- DKK 65,518
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -99 t. | -96 t. | 0 | 0 |
| 2024 | - | -92 t. | -100 t. | 25 t. | - |
| 2023 | - | -506 t. | -511 t. | -102 t. | - |
| 2022 | - | 1.3 mio. | 1.2 mio. | 409 t. | - |
| 2021 | - | -246 t. | -308 t. | -1.7 mio. | - |
Official annual report
How creditworthy is CONRIG PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
CONRIG PHARMA ApS has published its annual report for 2024. Gross profit came to DKK -92,016, and the net result was DKK -100,217.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Lars Christer Fredrik Fåhraeus and Snickar Karl Johan Tobieson. The board consists of Lars Christer Fredrik Fåhraeus, Niels Skjærbæk and Snickar Karl Johan Tobieson. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.